The Fund Managers intend to serve on the boards of directors for the majority of the companies in the portfolio...
HOUSE_OVERSIGHT_024042.jpg
This document is page 31 of a confidential investment strategy memorandum for New Leaf Venture Partners' third fund (NLV-III). It outlines the fund's strategy to invest in 24-28 companies, primarily in the U.S., with a 50-60% allocation focus on Biopharmaceuticals, alongside Information Convergence and Medical Devices. The document bears a House Oversight Bates stamp, indicating it was obtained as part of a congressional investigation, likely regarding financial connections.
Entities connected to both Fund Managers and Folio
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein relationship